Original Research
Published on 15 Sep 2022
Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial
in Sleep Disorders
Frontiers in Neurology
doi 10.3389/fneur.2022.901467
- 4,808 views
- 4 citations

